OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmaceuticals is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Antibody–Drug Conjugates: The Last Decade	223
Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity	171
Network Pharmacology Approach for Medicinal Plants: Review and Assessment	128
Towards Better Delivery of Cannabidiol (CBD)	120
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside	119
Lung Fibrosis after COVID-19: Treatment Prospects	118
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment	117
Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects	113
Dietary Effects of Anthocyanins in Human Health: A Comprehensive Review	112
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2	112
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery	104
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus	102
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies	102
1,2,4-Triazoles as Important Antibacterial Agents	101
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences	99
Bone Tissue Engineering in the Treatment of Bone Defects	97
COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials	95
Drug Design by Pharmacophore and Virtual Screening Approach	93
Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources	93
Antibacterials in Aquatic Environment and Their Toxicity to Fish	90
Emerging Applications of Nanotechnology in Healthcare Systems: Grand Challenges and Perspectives	88
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth	86
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review	84
Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications	84
Alginate Nanoformulation: Influence of Process and Selected Variables	82

[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer	81
Mycosporine-Like Amino Acids (MAAs): Biology, Chemistry and Identification Features	80
Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells	76
Silica-Based Bioactive Glasses and Their Applications in Hard Tissue Regeneration: A Review	68
Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia	68
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug	67
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer	66
Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies	66
G-Quadruplexes and Their Ligands: Biophysical Methods to Unravel G-Quadruplex/Ligand Interactions	65
Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme	65
Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges	64
An Overview of Cellulose Derivatives-Based Dressings for Wound-Healing Management	64
Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes	62
Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts	62
Covalently Functionalized Carbon Nano-Onions Integrated Gelatin Methacryloyl Nanocomposite Hydrogel Containing γ-Cyclodextrin as Drug Carrier for High-Performance pH-Triggered Drug Release	62
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease	61
Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update	61
Periodontal Wound Healing and Tissue Regeneration: A Narrative Review	61
Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis	61
The Chemistry Behind ADCs	61
Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies	60
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity	60
The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry	59
Chiral Switch: Between Therapeutical Benefit and Marketing Strategy	58
Recent Advances in Potential Health Benefits of Quercetin	58
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective	58
Autophagy as a Potential Therapy for Malignant Glioma	58
Advances in Antifungal Drug Development: An Up-To-Date Mini Review	57
Recent Advances in Green Synthesis, Characterization, and Applications of Bioactive Metallic Nanoparticles	56
Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer’s Disease and Ischemia-Related Brain Injury	56
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids	56
2020 FDA TIDES (Peptides and Oligonucleotides) Harvest	56